TIA Clinical Trials in Yantai, Shandong
2 recruitingYantai, Shandong, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals460 enrolled30 locationsNCT07357727
Recruiting
Phase 3
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
TIAIschemic Stroke, Acutesymptomatic intracranial artery stenosis
Beijing Tiantan Hospital4,674 enrolled5 locationsNCT06319846